KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Jul 02, 2026 - 3:59PM >>  ABB India 6861.15  [ -1.13% ]  ACC 1353.55  [ 1.55% ]  Ambuja Cements 428.95  [ 2.33% ]  Asian Paints 2742.6  [ 1.00% ]  Axis Bank 1363.75  [ -0.33% ]  Bajaj Auto 9859.35  [ 0.18% ]  Bank of Baroda 260.15  [ -4.18% ]  Bharti Airtel 1870.45  [ 0.01% ]  Bharat Heavy 402.1  [ -2.80% ]  Bharat Petroleum 310.45  [ 2.05% ]  Britannia Industries 5377.15  [ 2.31% ]  Cipla 1456.25  [ -0.05% ]  Coal India 438.7  [ 0.91% ]  Colgate Palm 2055.9  [ -0.73% ]  Dabur India 447  [ 0.43% ]  DLF 657.6  [ 1.34% ]  Dr. Reddy's Lab. 1340.55  [ 0.09% ]  GAIL (India) 174.2  [ -0.14% ]  Grasim Industries 3161.7  [ 0.68% ]  HCL Technologies 1077.5  [ 4.12% ]  HDFC Bank 796.25  [ 0.01% ]  Hero MotoCorp 4866.65  [ 0.65% ]  Hindustan Unilever 2210.7  [ 1.27% ]  Hindalco Industries 948.1  [ 0.90% ]  ICICI Bank 1399.9  [ 1.51% ]  Indian Hotels Co. 720.35  [ 0.11% ]  IndusInd Bank 943.45  [ 0.24% ]  Infosys 1041  [ 5.64% ]  ITC 289.95  [ -0.12% ]  Jindal Steel 1042.4  [ 1.33% ]  Kotak Mahindra Bank 399.6  [ -0.19% ]  L&T 4060.35  [ -0.78% ]  Lupin 2394  [ -0.10% ]  Mahi. & Mahi 3173.25  [ 1.39% ]  Maruti Suzuki India 14351  [ -0.43% ]  MTNL 30.4  [ 1.77% ]  Nestle India 1444.6  [ -0.61% ]  NIIT 104.25  [ 4.04% ]  NMDC 85.61  [ 1.43% ]  NTPC 358.35  [ 0.13% ]  ONGC 235.95  [ 0.34% ]  Punj. NationlBak 106.95  [ -0.51% ]  Power Grid Corpn. 288.2  [ 0.21% ]  Reliance Industries 1303.8  [ -0.32% ]  SBI 1051.8  [ 0.44% ]  Vedanta 276.15  [ 0.24% ]  Shipping Corpn. 303.55  [ 0.78% ]  Sun Pharmaceutical 1870.85  [ 0.26% ]  Tata Chemicals 688.8  [ 0.36% ]  Tata Consumer 1107.6  [ 1.51% ]  Tata Motors Passenge 346  [ -0.53% ]  Tata Steel 187.15  [ 1.08% ]  Tata Power Co. 376.3  [ 0.25% ]  Tata Consult. Serv. 2067.05  [ 4.28% ]  Tech Mahindra 1421.1  [ 4.32% ]  UltraTech Cement 11560.45  [ 0.88% ]  United Spirits 1369.95  [ 1.40% ]  Wipro 174.05  [ 2.35% ]  Zee Entertainment 107.15  [ -1.20% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

AAREY DRUGS & PHARMACEUTICALS LTD.

02 July 2026 | 03:15

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE198H01019 BSE Code / NSE Code 524412 / AAREYDRUGS Book Value (Rs.) 53.02 Face Value 10.00
Bookclosure 30/09/2024 52Week High 100 EPS 1.40 P/E 61.90
Market Cap. 245.55 Cr. 52Week Low 50 P/BV / Div Yield (%) 1.63 / 0.00 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
Aarey Drugs & Pharmaceuticals Ltd. (ADPL) was originally incorporated as a private limited company in the name of Niharika Textiles & Chemicals Pvt. Ltd. on 15th May 1990. The Aarey group of companie belonging to the Ghatalia group of companies took over the company and converted it into a public limited company on 18th march 1993. Its name was since changed to Aarey Drugs & Pharmaceuticals Ltd.

The main object of the company is to set up facilities for manufacture of bulk drugs. As an immediate step the company has undertaken a project to manufacture Metronidazole and Metronidazole Benzoate at its works situated at E-34, MIDC Estate.

2008

-Aarey Drugs & Pharmaceuticals Ltd has appointed Mr. Chetan Kiritbhai Mehta as an Independent Director of the Company from June 02, 2008.

2012

-Aarey Drugs & Pharmaceuticals Ltd Issues Rights in the Ratio of 2:1

-Aarey Drugs & Pharmaceuticals has given the Bonus in the Ratio of 1:5

2017 -The company has commenced production of new line of product Mefanamic Acid and has confirmed order for the same from its customers up till October, 2017.